GRI Bio, Inc. (GRI)
2.33
+0.08
(+3.56%)
USD |
NASDAQ |
Feb 13, 16:00
2.29
-0.04
(-1.72%)
After-Hours: 20:00
GRI Bio Shareholders Equity (Quarterly) : 6.008M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | -6.077M |
| Ekso Bionics Holdings, Inc. | 9.679M |
| Akari Therapeutics Plc | 22.69M |
| Moleculin Biotech, Inc. | -26.92M |
| Autonomix Medical, Inc. | 8.561M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.666M |
| Total Liabilities (Quarterly) | 2.658M |
| Debt to Equity Ratio | 0.0118 |
| Current Ratio | 3.251 |
| Net Debt Paydown Yield | 0.35% |